Purchase Order 75N93024P00341
Award Date 2/14/24
Potential Completion Date 4/13/24
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Psomagen Inc. has been awarded a firm fixed price purchase order from the Department of Health and Human Services Food and Drug Administration valued at $15,072.50 to provide whole genome sequencing and CVM Sanger services. The contract is set aside for total small businesses and will be completed by March 2023. Psomagen is a multiomics contract laboratory and data analysis provider that delivers genomic sequencing services to clinical, academic, and consumer markets. The company has...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $10,000.00 firm fixed-price purchase order is for DNA sequencing services. The contract has no set-aside designation. Psomagen Inc. is a provider of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, that supports...
- The National Institute of Allergy and Infectious Diseases awarded a $17,810 firm fixed price purchase order to Psomagen Inc. on September 13, 2021, with an ultimate completion date of August 4, 2022. This contract action was undertaken to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), in preparation for the September 30, 2026 closing of the period of availability for these fiscal year funds. The work was performed in...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $30,000 firm fixed-price purchase order was not set aside for any specific business type. Under this contract, Psomagen will provide a range of genomic and molecular biology services to support research across various NIH institutes, including the National Institute on Aging,...
- This federal contract award, valued at $44,940.00, was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a for-profit manufacturer of genomic sequencing and bioinformatics services. The contract is for "SEQUENCING NOVASEQX 25B 150PE, FLOW CELL" and has a firm fixed-price structure with a completion date of November 16, 2024. Psomagen Inc. is a subsidiary of Macrogen, Inc. and has...
- This is a federal contract award to Psomagen Inc., a subsidiary of Macrogen, Inc., by the National Institute of Allergy and Infectious Diseases (NIAID) to provide other functions for a total ceiling value of $6,000.00. The contract is a firm-fixed price purchase order with an ultimate completion date of October 23, 2013. Psomagen is a multiomics contract laboratory service and data analysis provider that specializes in delivering a wide range of genomic and molecular biology services to...
- The U.S. government awarded a $9,220 firm fixed-price purchase order to Psomagen Inc. for DNA library preparation and sequencing services, including additional quality control for replacement samples. The contract was set aside for small businesses and awarded on February 13, 2019, with an ultimate completion date of June 21, 2019. Work is being performed in Potomac, Maryland, and the funding agency is identified as the Northeast Area civilian federal agency component. Psomagen Inc., a...
- This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract, valued at $4,942.00, is for DNA sequencing services. It is not a set-aside contract. The contract supports NIAID's research efforts, potentially including work on neurodegenerative diseases, cancer, and infectious diseases. Psomagen has previously received...
- This federal contract award to Psomagen Inc., a subsidiary of Macrogen, Inc., is for epigenome sequencing services using the Illumina NovaSeq platform. The $83,750 firm fixed-price purchase order was awarded by the National Institute on Aging, a civilian agency within the National Institutes of Health. The award was not set aside for small businesses. Psomagen Inc. is an experienced provider of genomic services to federal agencies, having supported research initiatives at the NIH, USDA, and...
- The National Heart, Lung and Blood Institute awarded a purchase order to Psomagen Inc. for $33,223.00 on February 28, 2017, for DNA sequencing services. Ultimate completion was February 27, 2018. Work is performed at North Bethesda, Maryland. The order carries firm fixed price terms and no small business set-aside. Psomagen is a for-profit genomics and molecular biology services company and a subsidiary of Macrogen, Inc., operating CLIA-certified and CAP-accredited facilities that provide...